Aura Biosciences (AURA) Operating Income (2020 - 2026)
Aura Biosciences (AURA) posted Operating Income of -$34.9 million for Q1 2026, down 28.01% on a QoQ basis from -$27.2 million in Q4 2025, and down 20.08% year-over-year from -$43.6 million in Q1 2025.
Aura Biosciences (AURA) Operating Income (2020 - 2026) Analysis & Trends
Aura Biosciences' Operating Income history runs 7 years deep, the most recent figure standing at -$34.9 million for Q1 2026.
- Quarterly Operating Income fell 20.08% year-over-year to -$34.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$118.6 million (down 15.35% YoY) and the FY2025 annual result came in at -$112.8 million, down 17.35% from the prior year.
- Operating Income was -$34.9 million for Q1 2026 at Aura Biosciences, down from -$27.2 million in the prior quarter.
- Across five years, Operating Income topped out at -$12.8 million in Q1 2022 and bottomed at -$34.9 million in Q1 2026.
- A 5-year average of -$22.9 million and a median of -$22.8 million in 2024 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income tumbled 116.15% — and 2025, when it increased 2.05%.
- Aura Biosciences' Operating Income stood at -$17.6 million in 2022, then slumped by 40.71% to -$24.8 million in 2023, then decreased by 12.2% to -$27.8 million in 2024, then increased by 2.05% to -$27.2 million in 2025, then fell by 28.01% to -$34.9 million in 2026.
- Business Quant data shows AURA's Operating Income at -$34.9 million in Q1 2026, -$27.2 million in Q4 2025, and -$27.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Aura Biosciences | 474.16 Mn | 389.36 Mn | - | -34.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.87 Mn |
| Dec 31, 2025 | -27.24 Mn |
| Sep 30, 2025 | -27.91 Mn |
| Jun 30, 2025 | -28.61 Mn |
| Mar 31, 2025 | -29.04 Mn |
| Dec 31, 2024 | -27.81 Mn |
| Sep 30, 2024 | -23.23 Mn |
| Jun 30, 2024 | -22.76 Mn |
| Mar 31, 2024 | -22.31 Mn |
| Dec 31, 2023 | -24.78 Mn |
| Sep 30, 2023 | -20.49 Mn |
| Jun 30, 2023 | -20.28 Mn |
| Mar 31, 2023 | -19.44 Mn |
| Dec 31, 2022 | -17.61 Mn |
| Sep 30, 2022 | -16.06 Mn |
| Jun 30, 2022 | -13.82 Mn |
| Mar 31, 2022 | -12.81 Mn |
| Dec 31, 2021 | -11.63 Mn |
| Sep 30, 2021 | -8.90 Mn |
| Jun 30, 2021 | -8.80 Mn |